|
Essel Propack Q4 net profit up 66.1% at Rs 45.4 cr - last yr Rs 27.3 cr
|
|
Our Bureau, Mumbai
April 30 , 2015
|
|
|
Essel Propack, a global leader in laminated plastic tubes catering to
FMCG and pharma spaces, recently announced its financial results for the
quarter and full year ended March 31, 2015.
The company’s
consolidated quarterly (Jan 2015-March 2015) net profit was up 66.1 per
cent at Rs 45.4 crore as against Rs 27.3 crore in the corresponding
quarter of last year.
The consolidated revenue from global
operations during the quarter was up at Rs 611.7 crore, as against Rs
581.8 crore in Q4FY14. EBIDTA stood at Rs 106.2 crore up 19.6 per cent
as against Rs 88.8 crore in the same period last year.
For the
full year ended March 31, 2015, Essel’s consolidated revenue rose to Rs
2,323 crore up 9.2 per cent whereas the consolidated net profit for the
year stood at Rs 140.6 crore up 30.4 per cent as against Rs 107.8 crore
in FY14. EBIDTA for FY15 rose 11.8 per cent to Rs 396.2 crore compared
to Rs 354.5 crore in the same period last fiscal.
Ashok Goel, VC
& MD, Essel Propack Ltd, says, “With a record profit after tax of Rs
140 crore, it is a momentous three-year period growing our underlying
profit after tax at 30 per cent CAGR and topline at 14 per cent CAGR.
This impressive performance is a testimony of renewed energy in the
organisation to seize the opportunity that the expanded play field viz.
the value-added non-oral care category holds out for us. Having laid a
strong base by putting the necessary building blocks in place and with
our continuous innovations and new capabilities, the company looks to
continue its sustained profitable growth in the coming years towards the
goal of achieving 50 per cent revenues from non-oral care business.”
Americas
and Europe revenue posted robust growth with improved operating
efficiencies therefore margins. EAP continues to make strong progress in
expanding its non-oral care portfolio to offset slowdown in the oral
care category.
AMESA will continue to be a long-term opportunity
for FMCG albeit the slowdown witnessed in recent time in India. The
company is making good progress in expanding its market presence in
Egypt and the Middle-East across categories and further developing
pharma and cosmetic opportunity in the Indian market.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|